Uterine rupture as a complication of second trimester abortion using intraamniotic prostaglandin E2 and augmentation with other oxytocic agents.
Two cases of ruptured uterus are presented following attempted induction of midtrimester abortion using intraamniotic prostaglandin E2 and augmentation with other oxytocic agents. With continued uterine stimulation the diagnosis of rupture may not be obvious and the diagnostic features are discussed. Patients of high parity appear to be particularly susceptible to uterine rupture during induced midtrimester abortion.
D000019:Abortifacient Agents / Q000009:adverse effects*; D000020:Abortifacient Agents, Nonsteroidal / Q000009:adverse effects*; D000032:Abortion, Therapeutic / Q000009:adverse effects*; D000328:Adult; D005260:Female; D006801:Humans; D010121:Oxytocin / Q000627:therapeutic use; D011247:Pregnancy; D011262:Pregnancy Trimester, Second; D011458:Prostaglandins E / Q000009:adverse effects*; D014597:Uterine Rupture / Q000139:chemically induced*
D000019:Abortifacient Agents; D000020:Abortifacient Agents, Nonsteroidal; D011458:Prostaglandins E; D010121:Oxytocin